7-(3-methoxyphenyl)-4-piperidin-4-yl-1,4-diazepane-2,5-dione hydrochloride, 50mg

(2S,4R)-1-(tert-Butoxycarbonyl)-4-methylpyrrolidine-2-carboxylic acid, 97.0%, 100mg

6,7-Dihydro-4H-thieno[3,2-c]pyran-2-carboxylic acid, 95.0%, 10g

Acetobromo-a-D-glucuronic acid methyl ester, 95.0%, 5g

5-bromo-4-phenyl-1H-imidazole, 95.0%, 1g

5-(4-Boc-piperazino)-2-nitroanisole, 98%, 1g

2-[(pyrimidin-2-yl)amino]acetic acid, 95%, 1g

2-((2S,4R)-4-Hydroxypyrrolidin-2-yl)acetic acid hydrochloride, 95.0%, 100mg

4-(4-(1-Hydroxyethyl)-2-methoxy-5-nitrophenoxy)butanoic acid, 95.0%, 1g

ethyl 2-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-2-carboxylate, 10g

Récepteur à vide courbé 105°, 14/23, 14/23, 1 pièce

3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepine>98.0%(GC)5g

Sulfamethizole, 25g